March 29, 2017 3:49 AM ET

Biotechnology

Company Overview of Y's Therapeutics Co., Limited

Key Executives for Y's Therapeutics Co., Limited

NameBoard RelationshipsTitleAge
Masanori Murayama 11 RelationshipsFounder, Chief Executive Officer, President and Director56
Takaharu Itoh 11 RelationshipsChief Financial Officer and Director--
Nobuo Kato 11 RelationshipsChief Operating Officer, Vice President and Director--
Susumu Yamada 11 RelationshipsChief Business Officer and Director--

Y's Therapeutics Co., Limited Board Members*

NameBoard RelationshipsPrimary CompanyAge
Masanori Murayama 11 RelationshipsY's Therapeutics Co., Limited56
Takaharu Itoh 11 RelationshipsY's Therapeutics Co., Limited--
Nobuo Kato 11 RelationshipsY's Therapeutics Co., Limited--
Yutaro Kaneko 11 RelationshipsY's Therapeutics Co., Limited--
Susumu Yamada 11 RelationshipsY's Therapeutics Co., Limited--
View All Board Members

Y's Therapeutics Co., Limited Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
322.0K
Bonus
253.3K
Total Short Term Compensation
411.5K
Total Value of Options
2.7M
Compensation as of Fiscal Year
Y's Therapeutics Co., Limited CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Threshold Pharmaceuticals, Inc. and Molecular Templates, Inc. Announce Executive Appointments to Combined Company
March 27, 2017 9:01 PM ET
Threshold Pharmaceuticals, Inc. and Molecular Templates, Inc. Announce Executive Appointments to Combined Company
March 27, 2017 9:01 PM ET
Coherus BioSciences, Inc. Appoints Erik Wiberg as Executive Vice President of Corporate Development
March 27, 2017 9:00 PM ET
Aquinox Pharmaceuticals, Inc. Announces Board Appointments
March 27, 2017 8:02 PM ET
Aptose Biosciences Inc. Announces Resignation of Avanish Vellanki as Senior Vice President and Chief Business Officer
March 27, 2017 1:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Y's Therapeutics Co., Limited, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.